To further validate the anti-proliferative effect of CUDC-907, we performed clonogenic assays using four different NB cell lines, including two MYCN-amplified (LAN-5, NGP) and two non-amplified (SH-SY5Y, SK-N-AS) cell lines. Here, MYCN is linked to neuroblastoma.